Growth Metrics

CureVac N.V (CVAC) Operating Income: 2019-2025

Historic Operating Income for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$69.9 million.

  • CureVac N.V's Operating Income rose 11.84% to -$69.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $68.3 million, marking a year-over-year increase of 121.87%. This contributed to the annual value of $189.9 million for FY2024, which is 164.36% up from last year.
  • Per CureVac N.V's latest filing, its Operating Income stood at -$69.9 million for Q2 2025, which was down 21.41% from -$57.6 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Operating Income registered a high of $591.5 million during Q3 2024, and its lowest value of -$395.7 million during Q4 2024.
  • For the 3-year period, CureVac N.V's Operating Income averaged around -$38.7 million, with its median value being -$74.0 million (2023).
  • As far as peak fluctuations go, CureVac N.V's Operating Income tumbled by 392,922.67% in 2021, and later skyrocketed by 1,105.60% in 2024.
  • Quarterly analysis of 5 years shows CureVac N.V's Operating Income stood at -$6.3 million in 2021, then crashed by 1,866.40% to -$124.0 million in 2022, then rose by 23.61% to -$94.7 million in 2023, then tumbled by 317.89% to -$395.7 million in 2024, then climbed by 11.84% to -$69.9 million in 2025.
  • Its Operating Income stands at -$69.9 million for Q2 2025, versus -$57.6 million for Q1 2025 and -$395.7 million for Q4 2024.